The fact
This decision is based on the pharmaceutical group's growth prospects.
Sanofi remains a preferred stock in the healthcare sector.
Click the link to read an article on the topic:
This decision is based on the pharmaceutical group's growth prospects.
Sanofi remains a preferred stock in the healthcare sector.